Abstract

X-Linked Dystonia-Parkinsonism (XDP) is a neurodegenerative disease affecting individuals with ancestry to the island of Panay in the Philippines. In recent years there has been considerable progress at elucidating the genetic basis of XDP and candidate disease mechanisms in patient-derived cellular models, but the neural substrates that give rise to XDP in vivo are still poorly understood. Previous studies of limited XDP postmortem brain samples have reported a selective dropout of medium spiny neurons within the striatum, although neuroimaging of XDP patients has detected additional abnormalities in multiple brain regions beyond the basal ganglia. Given the need to fully define the CNS structures that are affected in this disease, we created a brain bank in Panay to serve as a tissue resource for detailed studies of XDP-related neuropathology. Here we describe this platform, from donor recruitment and consent to tissue collection, processing, and storage, that was assembled within a predominantly rural region of the Philippines with limited access to medical and laboratory facilities. Thirty-six brains from XDP individuals have been collected over an initial 4 years period. Tissue quality was assessed based on histologic staining of cortex, RNA integrity scores, detection of neuronal transcripts in situ by fluorescent hybridization chain reaction, and western blotting of neuronal and glial proteins. The results indicate that this pipeline preserves tissue integrity to an extent compatible with a range of morphologic, molecular, and biochemical analyses. Thus the algorithms that we developed for working in rural communities may serve as a guide for establishing similar brain banks for other rare diseases in indigenous populations.

Highlights

  • Brain donation plays a critical role in the study and understanding of human neurodegenerative disease (Kirch et al 1991; Stopa and Bird 1989; Trujillo Diaz et al 2018)

  • We developed a brain banking platform in the Philippines to create a repository of X-Linked Dystonia-Parkinsonism (XDP) brain tissue for characterizing the neuropathology of this disease

  • All procedures related to the collection, processing, and use of XDP patient post-mortem brain tissue were approved by institutional review boards at Makati Medical Center (Makati City, Philippines; protocol MMCIRB 2017-134) and Massachusetts General Hospital (Boston, MA, USA; protocol 2016p-000427)

Read more

Summary

Introduction

Brain donation plays a critical role in the study and understanding of human neurodegenerative disease (Kirch et al 1991; Stopa and Bird 1989; Trujillo Diaz et al 2018). X-Linked Dystonia-Parkinsonism (XDP) is an example of a progressive neurodegenerative disease in need of this approach, as its underlying neuropathology is not well understood and can only be directly assessed in postmortem brain tissue from clinically characterized donors. Recent genetic studies have linked XDP to a hexameric DNA repeat expansion, (CCCTCT)n, within a disease-specific insertion of a SINE-VNTR-Alu (SVA)type retrotransposon in the TAF1 gene (Bragg et al 2017; Makino et al 2007). The length of this repeat tract varies among XDP patients and inversely correlates with the age of disease onset (Bragg et al 2017; Westenberger et al 2019). In XDP cell models, the retrotransposon insertion disrupts splicing of TAF1, thereby decreasing levels of the full-length transcript (Aneichyk et al 2018)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call